This week, Ariosa Diagnostics announced the completion of the largest clinical study performed to date for noninvasive prenatal detection of common fetal trisomies. Ariosa is a molecular diagnostics company committed to providing safe, highly accurate and affordable prenatal tests for maternal and fetal health. Exciting news for expectant mothers!